Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2008-06-10
2008-06-10
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C558S070000, C558S155000, C558S166000, C558S169000
Reexamination Certificate
active
07384925
ABSTRACT:
Novel stilbenoid compounds and their prodrug forms are disclosed, which serve as potent vascular targeting agents useful for the treatment of solid tumor cancers and other diseases associated with unwanted neovascularization. The novel stilbenoid compounds are tubulin-binding stilbenoid analogs structurally related to combretastatin A-1 and combretastatin A-4. The prodrug forms serve as potent vascular targeting agents (VTAs) useful for the treatment of solid tumor cancers and diseases associated with retinal neovascularization.
REFERENCES:
patent: 5430062 (1995-07-01), Cushman et al.
patent: 5525632 (1996-06-01), Obsumi et al.
patent: 5561122 (1996-10-01), Pettit
patent: 5886025 (1999-03-01), Pinney
patent: 6214886 (2001-04-01), Potter et al.
patent: 6346550 (2002-02-01), Potter et al.
patent: 6479512 (2002-11-01), Fraley et al.
patent: 6919324 (2005-07-01), Chaplin et al.
patent: WO 92/16486 (1992-10-01), None
patent: WO 99/35150 (1999-07-01), None
Bedford et al.Bioorg. Med. Chem. Lett., 6(2):157-160 (1996).
Lin et al. Mol. Pharmacol.,34(2):200-208 (1988).
Orsini et al.Carbohydrate Res., 301(3-4):95-109 (1997).
Pettit et al.Anti-Cancer Drug Des., 10(4):299-309 (1995).
Pettit et al.Anti-Cancer Drug Des., 13(3):183-191 (1998).
Pettit et al. (1999) STN International, Caplus Database (Columbus, Ohio). Accession No. 1999:451301.
Supplementary Partial European Search Report for EP 02 79 7056, mailed Mar. 10, 2006.
Cushman, et al. (1992). J Med Chem 35:2293-2306.
Pettit, et al. (1998). J Med Chem 41: 1688-1695.
International Search Report for PCT/US 02/34497, mailed May 2, 2003.
Chaplin David J.
Edvardsen Klaus
Garner, III Charles Manly
Kane Robert Ronald
Pinney Kevin G.
Baylor University
Biswas Naomi S.
Elrifi Ivor R.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
OXiGENE, Inc.
LandOfFree
Functionalized stilbene derivatives as improved vascular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Functionalized stilbene derivatives as improved vascular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Functionalized stilbene derivatives as improved vascular... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2804526